Allergan tries to escape Restasis IPRs

10-01-2018

Allergan tries to escape Restasis IPRs

rocky89 / iStockphoto.com

Allergan is attempting to remove itself from a series of inter partes reviews focused on dry eye treatment Restasis (cyclosporine ophthalmic emulsion).


generics, Restasis, patent invalidation, Allergan, Saint Regis Mohawk Tribe, PTAB, IPR, sovereign immunity

LSIPR